Clinical Trials Directory

Trials / Completed

CompletedNCT02034305

Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy

Pilot Study of Cough Peak Flow And Airway Clearance in Pediatric Patients With Neuromuscular Disease

Status
Completed
Phase
Study type
Observational
Enrollment
7 (actual)
Sponsor
University of Pittsburgh · Academic / Other
Sex
Male
Age
6 Years – 21 Years
Healthy volunteers
Not accepted

Summary

This study is to determine whether physiologic measures (peak cough flow, measures of respiratory muscle strength including MIP, MEP ,SNIP, and spirometry) can predict spontaneous cough clearance (as measured by a nuclear medicine study) in children with neuromuscular disease. It will also determine whether airway clearance is augmented by high frequency chest wall oscillation.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2021-01-01
Completion
2021-01-01
First posted
2014-01-13
Last updated
2024-02-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02034305. Inclusion in this directory is not an endorsement.

Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy (NCT02034305) · Clinical Trials Directory